ICD-10-CM Billable Code

M62.52

Muscle wasting and atrophy, not elsewhere classified, upper arm

Clinical Classification Guidelines

Medical Intelligence & Overview

Muscle wasting and atrophy refer to the loss of muscle mass and strength, particularly in the upper arm, which can result from various underlying health conditions. This condition leads to a noticeable thinning of the affected muscles and can impact mobility, strength, and functionality. Recognizing the symptoms and causes of muscle atrophy in the upper arm is essential for diagnosis and management, although treatment options focus on addressing the root causes rather than the atrophy itself.

Causes & Symptoms

Clinical Causes: Nervous system disorders, such as nerve damage or compression (e.g., brachial plexus injuries, nerve entrapment syndromes) Prolonged inactivity or immobilization due to injury or illness Certain muscular dystrophies or genetic muscle disorders Chronic conditions like stroke or multiple sclerosis that impair nerve signals Malnutrition or significant weight loss, leading to muscle loss Inflammatory or autoimmune diseases, such as polymyositis or rheumatoid arthritis Aging-related muscle decline (sarcopenia) Cancer-related cachexia, causing generalized muscle wasting Toxic effects of certain medications or substances

Key Symptoms: Visible thinning or shrinking of the upper arm muscles Weakness in the affected arm, making it difficult to perform daily activities Reduced muscle strength and endurance during movement Flaccidity or softening of the muscle tissue Decreased muscle tone and firmness Potential difficulty with joint movement due to muscle loss Possible sensory changes if nerve involvement is present

Diagnostic & Treatment

Diagnosis Path: Muscle strength testing to assess the degree of weakness Electromyography (EMG) to evaluate nerve and muscle function Imaging studies such as magnetic resonance imaging (MRI) or ultrasound to visualize muscle tissue and identify structural changes Nerve conduction studies to check for nerve impairment Blood tests to detect inflammation, infection, or nutritional deficiencies Muscle biopsy in certain cases to examine muscle tissue at a cellular level

Treatment Protocols: Physical therapy and targeted exercises to maintain or improve muscle strength and flexibility Addressing nerve damage through medication, surgical intervention, or other therapies Nutritional support and dietary interventions to promote muscle health Medications to control inflammatory or autoimmune conditions Use of assistive devices to aid mobility and function Managing chronic illnesses effectively to prevent further muscle deterioration In some cases, surgical procedures may be necessary to repair nerve damage or correct structural issues

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M62.52 a billable ICD-10 code?
Yes, M62.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M62.52?
Clinical documentation must specify the nature of Muscle wasting and atrophy, not elsewhere classified, upper arm and any associated comorbidities for accurate reporting.

Cite this Clinical Reference